N-of-One® Presents Data at AACR-EORTC-NCI Meeting Showing Common Breast Cancer Mutation Also Present in Other Cancers, Expanding Targeted Treatment Options

  • Posted by 3mediaweb
  • On October 22, 2013
  • 0 Comments
— Poster Presentation Details Findings Based on N-of-One® Interpretation of Next-Generation Sequencing Data from more than 4,000 Cancer Patients — WALTHAM, Mass., October 22, 2013—N-of-One, Inc., the leading provider of molecular interpretation and therapeutic strategies for personalized cancer care, presented data at the 2013 AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Conference identifying additional treatment options […]
Read More

N-of-One® Selected by Life Technologies to Provide Valuable Employee Benefit: Molecular Diagnostics and Treatment Strategies for Personalized Cancer Care

  • Posted by 3mediaweb
  • On October 16, 2013
  • 0 Comments
—New Employee Benefit Makes Knowledge of Targeted Therapies Available to Employees, Family Members Fighting Cancer, and Their Treating Oncologists to Inform Treatment Decisions — —N-of-One Services are Scalable for Employers of All Sizes — WALTHAM, Mass., October 16, 2013—N-of-One, Inc., a leading provider of molecular interpretation and therapeutic strategies for personalized cancer care, today announced […]
Read More
BACK TO
TOP
LEARN
MORE